Professor Vikas Prasad is Director Clinical Theranostics at the Mallinckrodt Institute of Radiology, St. Louis, USA. With over 120 publications, his clinical expertise and research interest include Peptide Receptor Radionuclide Therapy (PRRT) of neuroendocrine tumors and prostate cancer, integration of molecular markers for molecular imaging, development of new software for molecular imaging using radiolabeled substances and development of new response evaluation criteria applicable to PET/CT and PET/MRI. Professor Prasad leads the Theranostic Task Force within ENETS Advisory Board and takes active part in the Theranostics AG of the German Nuclear Medicine Society (DGN). Moreover he is an ESMO Faculty and the ICPO Academy leader for the RPO pillar